February 24, 2017 9:02 am
The new approach being developed by academics in the UK and Europe, uses dye molecules and light to kill bacteria, fungi, viruses and protozoa.
February 22, 2017 3:32 pm
Over the last decade, the cost of sequencing an individual’s genome has plunged from about $10 million to about $1,000.
February 21, 2017 10:53 am
Pfizer is getting closer to gaining regulatory approval for an investigational leukemia treatment called inotuzumab ozogamicin.
February 20, 2017 3:00 pm
With a total of 2,145 products currently in development, the immunology market is experiencing a high level of investment compared to many other therapy areas.
February 17, 2017 2:40 pm
British-based pharmaceutical firm AstraZeneca may be gaining an advantage in the burgeoning PARP inhibitor drug space.
February 17, 2017 8:35 am
Pluripotent stems cells can differentiate into any type of adult cell and have potential for tissue regeneration therapies, treating diseases and for research.
February 16, 2017 2:19 pm
Boston-based Rhythm Pharmaceuticals obtained a new round of funding to help continue development of its lead peptide therapy setmelanotide.
February 15, 2017 2:46 pm
A promising multiple sclerosis treatment called Ocrevus will play a crucial role in this growth.
February 15, 2017 8:41 am
Investigators will gain a five-year appointment and up to $1.5 million in funding to kick start their research projects.
February 14, 2017 2:38 pm
Ibrance and ribociclib are poised to dominate this drug class in terms of sales.
- 1 of 5
- next ›